Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice

In the AMPLIFY clinical trial, apixaban was non-inferior to warfarin plus subcutaneous enoxaparin bridge therapy in the treatment of acute venous thromboembolism (VTE) and was associated with significantly less bleeding. This study evaluated their comparative effectiveness and safety in routine clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Weycker, Derek, Li, Xiaoyan, Wygant, Gail DeVecchis, Lee, Theodore, Hamilton, Melissa, Luo, Xuemei, Vo, Lien, Mardekian, Jack, Pan, Xianying, Burns, Leah, Atwood, Mark, Hanau, Ahuva, Cohen, Alexander T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206509/
https://www.ncbi.nlm.nih.gov/pubmed/30357780
http://dx.doi.org/10.1055/s-0038-1673689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206509/
https://www.ncbi.nlm.nih.gov/pubmed/30357780
http://dx.doi.org/10.1055/s-0038-1673689

Ejemplares similares